Rotella Capital Management’s Altimmune ALT Stock Holding History

Rotella Capital Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-40	Closed	-$22K	–	505
2014 Q4	$22K	Sell	40 -38	-49%	-$19.5K	0.02%	341
2014 Q3	$41K	Sell	78 -87	-53%	-$45.5K	0.04%	257
2014 Q2	$71K	Buy	165 +70	+74%	+$31.6K	0.06%	274
2014 Q1	$52K	Buy	95 +61	+179%	+$35.6K	0.06%	168
2013 Q4	$19K	Sell	34 -28	-45%	-$16.7K	0.04%	95
2013 Q3	$39K	Sell	62 -62	-50%	-$35.5K	0.07%	95
2013 Q2	$59K	Buy	+124	New	+$61.5K	0.19%	73

Other funds holding ALT

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

GMCM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Rotella Capital Management's ALT Position: Q1 2015 in Review

Rotella Capital Management sold out of Altimmune (ALT) in Q1 2015, closing a stake of 40 shares — an estimated $22K sold.

Rotella Capital Management first reported a position in ALT in Q2 2013 and held it in 7 quarters. The position peaked at $71K in Q2 2014. 36 funds tracked by Wall St. Rank hold ALT as of Q1 2015.

Rotella Capital Management reported no remaining Altimmune position as of Q1 2015 after selling out during the quarter.
Rotella Capital Management sold 40 Altimmune shares in Q1 2015, an estimated $22K.
Rotella Capital Management first reported a position in Altimmune in Q2 2013 and held it in 7 quarters.
Rotella Capital Management's Altimmune position peaked at $71K in Q2 2014.
36 funds tracked by Wall St. Rank held Altimmune as of Q1 2015.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.